Effect of Lavender Essential Oil Formulation on Hair loss

Evaluating the Effectiveness of Nanostructured Lipid Carriers Containing Lavender Essential Oil Compared to 2% Minoxidil for Androgenic Hair loss; Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241015063373N1

Enrollment

Registered

2025-01-08

Start date

2024-10-31

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic Alopecia. Androgenic alopecia

Interventions

Intervention 1: Intervention group: In the Intervention Group, Lipid Nanostructure Formulation Containing Lavender Essential Oil will be used. In order to prepare Lipid Nanostructures, a High-speed Ho

Eligibility

Sex/Gender

Male

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: Male Sex Progressive Symptoms of Hair loss in the Frontotemporal Area

Exclusion criteria

Exclusion criteria: Any Manifestation of Skin Disease in the Study Area Allergy or Hypersensitivity Reaction to Medicinal Products or Components of the Study Product History of Skin Cancer Acute or Chronic Disease that could Interfere with the Study Use of Topical or Systemic Medications or Cosmetic Products that could Interfere with the Study

Design outcomes

Primary

Measure	Time frame
Percentage Change in Hair Density per unit of Specified Scalp Area. Timepoint: Before the Start of the Intervention, 12 Weeks after the Start of the Intervention, immediately after the End of the Intervention (24 weeks). Method of measurement: Dermatoscope Device, Yinama Model, Made in China.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Farshidi

Tabriz University of Medical Sciences

farshidimahsa8@gmal.com+98 41 3288 1744

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026